(MedPage Today) — The FDA approved veligrotug (Lumvoa) for the treatment of thyroid eye disease (TED), regardless of disease activity or duration, Viridian Therapeutics announced on Friday.
Veligrotug is the first treatment with labeling for…
Source link : https://www.medpagetoday.com/endocrinology/thyroid/121972
Author :
Publish date : 2026-06-29 19:20:00
Copyright for syndicated content belongs to the linked Source.
